About EntheogeniX Biosciences
EntheogeniX Biosciences is a biotech company dedicated to advancing psychedelic research for the development of better medicines for mental health diseases such as depression, bipolar disorder, and schizophrenia.
Missing: EntheogeniX Biosciences's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: EntheogeniX Biosciences's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing EntheogeniX Biosciences
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
EntheogeniX Biosciences is included in 2 Expert Collections, including Psychedelics.
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
EntheogeniX Biosciences Frequently Asked Questions (FAQ)
When was EntheogeniX Biosciences founded?
EntheogeniX Biosciences was founded in 2019.
Where is EntheogeniX Biosciences's headquarters?
EntheogeniX Biosciences's headquarters is located at Wilmington.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.